<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Mol Biosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Mol Biosci</journal-id><journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id><journal-title-group><journal-title>Frontiers in Molecular Biosciences</journal-title></journal-title-group><issn pub-type="epub">2296-889X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7750483</article-id><article-id pub-id-type="doi">10.3389/fmolb.2020.599340</article-id><article-categories><subj-group subj-group-type="heading"><subject>Molecular Biosciences</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>m<sup>5</sup>C RNA Methylation Primarily Affects the ErbB and PI3K&#x02013;Akt Signaling Pathways in Gastrointestinal Cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Shixin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Yongshun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/667106/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Yueshui</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/701053/overview"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/676836/overview"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Mingxing</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Xiao</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kaboli</surname><given-names>Parham Jabbarzadeh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Fukuan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ji</surname><given-names>Huijiao</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wen</surname><given-names>Qinglian</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Zhangang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/773488/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University</institution>, <addr-line>Luzhou</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>South Sichuan Institute of Translational Medicine</institution>, <addr-line>Luzhou</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Neijiang Health and Health Vocational College</institution>, <addr-line>Neijiang</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Oncology and Hematology, Hospital (T.C.M.) Affiliated to Southwest Medical University</institution>, <addr-line>Luzhou</addr-line>, <country>China</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Oncology, Affiliated Hospital of Southwest Medical University</institution>, <addr-line>Luzhou</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Saber Imani, Affiliated Hospital of Southwest Medical University, China</p></fn><fn fn-type="edited-by"><p>Reviewed by: Maria Celeste Cantone, Istituto Auxologico Italiano (IRCCS), Italy; Mazaher Maghsoudloo, University of Tehran, Iran; Amit Kumar Pandey, Amity University Gurgaon, India</p></fn><corresp id="c001">*Correspondence: Zhangang Xiao, <email>xzg555898@hotmail.com</email></corresp><corresp id="c002">Qinglian Wen, <email>wql73115@163.com</email></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>These authors have contributed equally to this work</p></fn><fn fn-type="other" id="fn004"><p>This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>7</volume><elocation-id>599340</elocation-id><history><date date-type="received"><day>27</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>28</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Xiang, Ma, Shen, Zhao, Wu, Li, Yang, Kaboli, Du, Ji, Zheng, Li, Li, Wen and Xiao.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Xiang, Ma, Shen, Zhao, Wu, Li, Yang, Kaboli, Du, Ji, Zheng, Li, Li, Wen and Xiao</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>5-Methylcytosine (m<sup>5</sup>C) is a kind of methylation modification that occurs in both DNA and RNA and is present in the highly abundant tRNA and rRNA. It has an important impact on various human diseases including cancer. The function of m<sup>5</sup>C is modulated by regulatory proteins, including methyltransferases (writers) and special binding proteins (readers). This study aims at comprehensive study of the m<sup>5</sup>C RNA methylation-related genes and the main pathways under m<sup>5</sup>C RNA methylation in gastrointestinal (GI) cancer. Our result showed that the expression of m<sup>5</sup>C writers and reader was mostly up-regulated in GI cancer. The <italic>NSUN2</italic> gene has the highest proportion of mutations found in GI cancer. Importantly, in liver cancer, higher expression of almost all m<sup>5</sup>C regulators was significantly associated with lower patient survival rate. In addition, the expression level of m<sup>5</sup>C-related genes is significantly different at various pathological stages. Finally, we have found through bioinformatics analysis that m<sup>5</sup>C regulatory proteins are closely related to the ErbB/PI3K&#x02013;Akt signaling pathway and <italic>GSK3B</italic> was an important target for m<sup>5</sup>C regulators. Besides, the compound termed streptozotocin may be a key candidate drug targeting on GSK3B for molecular targeted therapy in GI cancer.</p></abstract><kwd-group><kwd>m<sup>5</sup>C</kwd><kwd>RNA methylation</kwd><kwd>ErbB</kwd><kwd>PI3K&#x02013;Akt</kwd><kwd>gastrointestinal cancer</kwd><kwd>survival</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source><award-id rid="cn001">81602166</award-id><award-id rid="cn001">81672444</award-id></award-group><award-group><funding-source id="cn002">Department of Science and Technology of Sichuan Province<named-content content-type="fundref-id">10.13039/501100004829</named-content></funding-source><award-id rid="cn002">2018JY0079</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="1"/><equation-count count="0"/><ref-count count="79"/><page-count count="17"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>Gastrointestinal (GI) cancer is one of the leading causes of death worldwide. It refers to cancers of the upper and lower digestive tracts and mainly includes colorectal adenocarcinoma (CRC), gastric cancer (GC), pancreatic cancer (PC), hepatocellular carcinoma (HCC), and esophageal cancer (EC) (<xref rid="B56" ref-type="bibr">Toomey et al., 2013</xref>). Nearly 4.1 million people are diagnosed with GI cancer each year. Epigenetic changes are common events in both initiation and progression of GI cancer (<xref rid="B60" ref-type="bibr">Vedeld et al., 2018</xref>). Currently, there are many ways to treat GI cancer. However, most of the treatment outcomes are still poor (<xref rid="B4" ref-type="bibr">Bilgin et al., 2017</xref>).</p><p>RNA methylation modifications mainly include m<sup>6</sup>A, m<sup>5</sup>C, m<sup>1</sup>A, m<sup>7</sup>G, and so on. Previous studies have shown that these modifications play important roles in the stability, processing, and genetic information transmission of mRNA (<xref rid="B34" ref-type="bibr">Liu and Jia, 2014</xref>; <xref rid="B41" ref-type="bibr">Oerum et al., 2017</xref>). Known mutations in RNA-modifying enzymes are closely related to human diseases, including cancers, cardiovascular diseases, metabolic diseases, and mitochondrial-related defects (<xref rid="B22" ref-type="bibr">Jonkhout et al., 2017</xref>). The degree of methylation of specific genes can be used as a diagnostic indicator of cancer (<xref rid="B32" ref-type="bibr">Li W. et al., 2017</xref>; <xref rid="B57" ref-type="bibr">Traube and Carell, 2017</xref>). 5-Methylcytosine (m<sup>5</sup>C) includes DNA and RNA methylation modifications, in which the methyl group is transferred to a specific base by using <italic>S</italic>-adenosylmethionine (SAM) as a methyl donor under the catalysis of methyltransferase. m<sup>5</sup>C RNA modification has been found to be highly abundant in tRNA and rRNA (<xref rid="B39" ref-type="bibr">Motorin et al., 2010</xref>). Meanwhile, high throughput sequencing has been used to verify the widespread presence of m<sup>5</sup>C in non-coding RNA and coding RNA (<xref rid="B49" ref-type="bibr">Squires et al., 2012</xref>). It has been reported that m<sup>5</sup>C modification controls many functions: protein translational regulation, RNA processing, regulating stem cell function and stress response, and promoting tRNA stability and protein synthesis (<xref rid="B3" ref-type="bibr">Aslan et al., 1967</xref>; <xref rid="B5" ref-type="bibr">Blanco et al., 2016</xref>; <xref rid="B35" ref-type="bibr">Liu et al., 2017</xref>; <xref rid="B59" ref-type="bibr">Tuorto et al., 2012</xref>). However, the involvement of m<sup>5</sup>C modification in GI cancer has not been systematically reported yet.</p><p>5-Methylcytosine modification is regulated by methyltransferases (writers, including <italic>NSUN1-7</italic> and <italic>TRDMT1</italic> [<italic>tRNA aspartic acid methyltransferase 1</italic>]) and binding protein (reader, i.e., <italic>ALYREF</italic> [<italic>Aly/REF export factor</italic>]). <italic>NSUN1-7</italic> and <italic>TRDMT1</italic> are known writers for chemical RNA modifications (<xref rid="B19" ref-type="bibr">Jacob et al., 2017</xref>). <italic>NSUN1</italic> (NOP2 nucleolar protein/rRNA MTase) plays an important role in maintaining cell proliferation capacity and is possibly involved in the regeneration of nervous tissue (<xref rid="B25" ref-type="bibr">Kosi et al., 2015</xref>; <xref rid="B17" ref-type="bibr">Hong et al., 2016</xref>). <italic>NSUN2</italic> (<italic>NOP2/Sun RNA methyltransferase 2/</italic>mRNA and tRNA MTase) is a main RNA modification methyltransferase. Its mechanism of action includes controlling cell division, growth arrest, and promoting premature senescence (<xref rid="B69" ref-type="bibr">Xing et al., 2015</xref>; <xref rid="B6" ref-type="bibr">Cai et al., 2016</xref>; W. <xref rid="B63" ref-type="bibr">Wang, 2016</xref>; <xref rid="B71" ref-type="bibr">Yang X. et al., 2017</xref>). It has been reported that <italic>NSUN2</italic> mutations lead to intellectual disability in human diseases (<xref rid="B1" ref-type="bibr">Abbasi-Moheb et al., 2012</xref>). <italic>NSUN3</italic> (NOP2/Sun RNA methyltransferase 3/mt-tRNA MTase) and <italic>NSUN4</italic> (NOP2/Sun RNA methyltransferase 4/mt-rRNA MTase) have important impacts on the mitochondria (<xref rid="B38" ref-type="bibr">Metodiev et al., 2014</xref>; <xref rid="B46" ref-type="bibr">Schosserer et al., 2015</xref>; <xref rid="B40" ref-type="bibr">Nakano et al., 2016</xref>). <italic>NSUN5</italic> (NOP2/Sun RNA methyltransferase 5/rRNA MTase) is a conserved rRNA methyltransferase (<xref rid="B46" ref-type="bibr">Schosserer et al., 2015</xref>). <italic>NSUN6</italic> (NOP2/Sun RNA methyltransferase 6/tRNA MTase) modifies tRNAs in their biogenesis (<xref rid="B15" ref-type="bibr">Haag et al., 2015</xref>). <italic>NSUN7</italic> (<italic>NOP2/Sun RNA methyltransferase family member 7</italic>) gene product plays a role in sperm motility (<xref rid="B24" ref-type="bibr">Khosronezhad et al., 2015</xref>). <italic>TRDMT1</italic> (also known as <italic>DNMT2</italic>) was previously considered as a DNA MTase, but it is now primarily regarded as a tRNA MTase (<xref rid="B45" ref-type="bibr">Schaefer and Lyko, 2010</xref>; <xref rid="B49" ref-type="bibr">Squires et al., 2012</xref>; <xref rid="B20" ref-type="bibr">Jeltsch et al., 2017</xref>). Up to now, the m<sup>5</sup>C eraser is still unknown, and the only known binding protein (reader) of m<sup>5</sup>C is <italic>ALYREF</italic>. <italic>ALYREF</italic> as an m<sup>5</sup>C reader can promote mRNA export (<xref rid="B71" ref-type="bibr">Yang X. et al., 2017</xref>). In general, m<sup>5</sup>C methyltransferases are strongly associated with diseases.</p><p>Currently, there is little research progress in the biological function and mechanism of m<sup>5</sup>C in GI cancer. In this study, we analyzed the gene expression level, alteration frequency, and association with survival of m<sup>5</sup>C regulators in GI cancer. Meanwhile, we also studied their related pathways and key target, for which a druggable compound was found in the hope of providing new treatment for patients with GI cancer.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2.SS1"><title>Data Processing</title><p>The expression level and clinical data of m<sup>5</sup>C regulators in five types of GI cancers were extracted from the TCGA database<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> (<xref rid="B55" ref-type="bibr">Tomczak et al., 2015</xref>) (download date: 2019-05-05). There were 1,696 cancer samples and 148 normal samples. The standardized TCGA and GTEX transcriptome data are derived from the UCSC database<sup><xref ref-type="fn" rid="footnote2">2</xref></sup>. In total, there were 1,451 cancer samples and 1,044 normal samples.</p></sec><sec id="S2.SS2"><title>Somatic Alteration Analysis</title><p>The cBioportal analysis of the GISTIC 2.0 database was used to analyze the alteration frequency and percentage of m<sup>5</sup>C regulatory factors in GI cancers and protein affected by m<sup>5</sup>C regulators (<xref rid="B7" ref-type="bibr">Cerami et al., 2012</xref>). OncoPrint can summarize distinct genomic alterations across samples in the m<sup>5</sup>C regulatory factors, including mutations, CNAs, and changes in gene expression or protein abundance (<xref rid="B13" ref-type="bibr">Gao et al., 2013</xref>).</p></sec><sec id="S2.SS3"><title>Protein Structure Alteration</title><p>The protein structure alteration was analyzed in cBioportal using the Mutations tab. The query was limited to respective m<sup>5</sup>C regulatory factors in different types of GI cancer. Lollipop of each protein structure change of GI cancer was linked to COSMIC (<xref rid="B54" ref-type="bibr">Tate et al., 2019</xref>). The detailed mutation annotation was originated from OncoKB, CIViC, and Hotspot (<xref rid="B54" ref-type="bibr">Tate et al., 2019</xref>).</p></sec><sec id="S2.SS4"><title>Pathway Analysis</title><p>Proteomic data were collected by Reverse Phase Protein Array (RPPA) based on TCGA data from cBioportal<sup><xref ref-type="fn" rid="footnote3">3</xref></sup>. For the enriched proteins, significant change in expression was determined by the standard of log<sub>2</sub> based ratio (&#x003bc; mean altered/&#x003bc; mean unaltered) (log &#x0003e; 0 for over-expression and log &#x0003c; 0 for under-expression) and queried event results in <italic>P</italic> value &#x0003c;0.05. The -log<sub>10</sub>
<italic>P</italic> value &#x0003e;1.30 proteins were selected for further downstream pathway analysis. Differential proteins are shown by the volcano plot using GraphPad Prism 7. The selected proteins from this criterion were used to predict pathways by two conditions: (a) the sum of altered protein in each pathway and (b) the statistical <italic>P</italic> value score of significant pathway (<xref rid="B28" ref-type="bibr">Li D. et al., 2020</xref>). Finally, the screened differential proteins were used to predict the pathway in the DAVID function annotation tool<sup><xref ref-type="fn" rid="footnote4">4</xref></sup>.</p></sec><sec id="S2.SS5"><title>Gene Ontology Analysis</title><p>The Gene Ontology (GO) enrichment analysis of the m<sup>5</sup>C RNA methylation modification was analyzed <italic>via</italic> the DAVID function annotation tool (<xref rid="B10" ref-type="bibr">Dennis et al., 2003</xref>). GO contains biological processes, cell components, and molecular functions. In this analysis, count represents the number of genes contained in the GO term. Therefore, the count and <italic>P</italic> values are considered together to obtain important metabolic process.</p></sec><sec id="S2.SS6"><title>Protein&#x02013;Protein Interaction Network Analysis</title><p>We analyzed the network of interactions between proteins by using the STRING and Cytoscape software. The STRING database is a meta resource, including both physical and functional interactions (<xref rid="B21" ref-type="bibr">Jensen et al., 2009</xref>). STRING can be reached at <ext-link ext-link-type="uri" xlink:href="http://string-db.org/">http://string-db.org/</ext-link>. The minimum required interaction score is set to medium confidence and select all active interaction sources. Cytoscape is a public software that can integrate models of biomolecular interaction networks (<xref rid="B47" ref-type="bibr">Shannon et al., 2003</xref>).</p></sec><sec id="S2.SS7"><title>Correlation and Co-expression Analysis</title><p>To better understand the co-expression between m<sup>5</sup>C regulatory factors and the differentially expressed genes (DEGs) associated with key downstream pathways, we used the R statistical software by R package heatmap (<xref rid="B8" ref-type="bibr">Chan, 2018</xref>). Parameters of co-expression analysis were set as: 0.8&#x02013;1.0 strongly correlated, 0.6&#x02013;0.8 strong correlation, 0.4&#x02013;0.6 moderate intensity correlation, 0.2&#x02013;0.4 weak correlation, and 0.0&#x02013;0.2 very weak correlation or no correlation. Correlation between <italic>GSK3B</italic> (<italic>glycogen synthase kinase 3 beta</italic>) and m<sup>5</sup>C regulators was analyzed using the linear regression. The 95% confidence intervals were presented by dot lines. The data have been standardized.</p></sec><sec id="S2.SS8"><title>Network Pharmacology Analysis</title><p>Differentially expressed genes related to the <italic>GSK3B</italic> gene were obtained by R package limma. The samples were divided into two groups according to the median expression values of the <italic>GSK3B</italic> gene and | log<sub>2</sub> fold-change (FC)| &#x0003e; 1, and the <italic>P</italic> value &#x0003c;0.05 was set as a threshold. According to the <italic>P</italic> value ranking, the first 150 DEGs that were significantly up-regulated and the first 150 DEGs that were significantly down-regulated were included for potential drug target analysis. The Connectivity Map (CMap) is a gene expression profile database based on interventional gene expression (<xref rid="B50" ref-type="bibr">Subramanian et al., 2017</xref>). It is mainly used to analyze the functional connections between small molecule compounds, genes, and diseases (<xref rid="B27" ref-type="bibr">Lamb et al., 2006</xref>). PharmMapper is a comprehensive target pharmacophore database that can search potential drug target identification (<xref rid="B65" ref-type="bibr">Wang et al., 2017</xref>). PharmMapper comes from TargetBank, DrugBank, BindingDB, and potential drug target databases, and nearly 53,000 receptor-based pharmacophore models are used for prediction (<xref rid="B36" ref-type="bibr">Liu et al., 2010</xref>; <xref rid="B64" ref-type="bibr">Wang et al., 2016</xref>).</p></sec><sec id="S2.SS9"><title>Statistical Analysis</title><p><italic>T</italic> test is used for comparison between two groups of data, and one-way ANOVA is applied to compare multiple groups. Survival analysis was performed using Kaplan&#x02013;Meier curve with <italic>P</italic> value calculated using the log-rank test. The correlation of mRNA expression was analyzed by Pearson test. Chi-square test was used to test the association of m<sup>5</sup>C regulator expression with clinicopathological parameters. <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec id="S3"><title>Results</title><sec id="S3.SS1"><title>The Expression Level of m<sup>5</sup>C Regulators in GI Cancer</title><p>The workflow of the study and nomenclature and mechanism of m<sup>5</sup>C writer and reader was demonstrated in <xref ref-type="fig" rid="F1">Figures 1A,B</xref>. To characterize the expression of m<sup>5</sup>C writers and reader in GI cancer, we first used the TCGA data. Overall, the expression level of <italic>NSUN3</italic>, <italic>NSUN4</italic>, <italic>NUSN6</italic>, <italic>NUSN7</italic>, and <italic>TRDMT1</italic> was lower than that of other m<sup>5</sup>C regulators (<xref ref-type="fig" rid="F2">Figure 2A</xref>). When comparing the expression level between 1,696 cancer and 148 normal samples, heat map showed that the expression of m<sup>5</sup>C writers and reader was generally higher in GI cancer than in normal samples (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The combination of the TCGA and GTEX databases was used to compare the expression level of m<sup>5</sup>C writer and reader between tumor tissue and normal samples in GI cancer. The results indicated that writers and reader were mostly up-regulated in GI cancer (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Meanwhile, we did principal component analysis of gene expression in 1,695 samples of the five cancer types (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure S1</xref>). X and Y axes explained 39.5 and 16.4% of the total variance, respectively. The further apart the two samples, the greater the difference in genetic background between them would be. From the figure, the five cancers were almost distinctively separated.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Comprehensive molecular profiling of m<sup>5</sup>C writers and reader in GI cancer. <bold>(A)</bold> The workflow of the study. <bold>(B)</bold> The regulation mechanism of m<sup>5</sup>C in GI cancers (esophageal cancer, liver cancer, gastric cancer, colon cancer, and rectal cancer). m<sup>5</sup>C formation is catalyzed by writer and SAM (<italic>S</italic>-adenosylmethionine). In addition, reader can recognize methylated mRNA and mediate its export from the nucleus. They work together on m<sup>5</sup>C RNA methylation modification.</p></caption><graphic xlink:href="fmolb-07-599340-g001"/></fig><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Expression of m<sup>5</sup>C writers and reader in GI cancer. <bold>(A)</bold> Based on RNA sequencing data from the TCGA database, a heat map of m<sup>5</sup>C writer and reader expression was drawn. Data were collected from cancer patients (<italic>n</italic> = 1,568) and healthy patients (<italic>n</italic> = 139). Each sample was normalized and was represented by a square. Red and blue regions represented higher and lower expression levels, respectively. <bold>(B)</bold> RNA sequencing data were used to compare the expression level of each m<sup>5</sup>C regulator between tumor and normal samples in different GI cancer types.</p></caption><graphic xlink:href="fmolb-07-599340-g002"/></fig></sec><sec id="S3.SS2"><title>Mutation of m<sup>5</sup>C Regulators</title><p>In order to identify mutations of m<sup>5</sup>C regulators, cBioPortal for Cancer Genomic was used (<xref rid="B7" ref-type="bibr">Cerami et al., 2012</xref>; <xref rid="B13" ref-type="bibr">Gao et al., 2013</xref>). As shown in <xref ref-type="fig" rid="F3">Figures 3A,B</xref>, mutation and amplification were frequently seen in m<sup>5</sup>C regulators. <italic>NSUN2</italic>, <italic>NSUN5</italic>, and <italic>ALYREF</italic> showed relatively higher copy number amplification. In <xref ref-type="fig" rid="F3">Figure 3B</xref>, we also found that there are many types of mutations in m<sup>5</sup>C RNA methylation regulators, such as inframe mutation, missense mutation, amplification, and deep deletion. Among them, amplification has the largest proportion of types, and deep deletion also accounts for a large proportion. Overall, about 13% of the samples (246/1,924) had genetic changes, and the mutation rate of m<sup>5</sup>C regulators was relatively higher in esophagus and stomach cancers than in other cancer types. Furthermore, 28% (52/186) of EC, 8% (14/186) of PC, 19% (91/478) of stomach cancer, 5% (33/640) of colorectal cancer, 13% (56/442) of liver cancer, and 12% (234/1,928) of GI cancer had genomic changes of m<sup>5</sup>C regulators. Notably, the mutation frequencies of <italic>NSUN2</italic> in esophagus and stomach cancers, <italic>NSUN3</italic> in esophagus cancer, and <italic>ALYREF</italic> in liver cancer were particularly high. Changes in protein structure were shown in <xref ref-type="fig" rid="F3">Figure 3C</xref>. Mutation in protein sequence was more often found in <italic>NSUN1</italic> and <italic>NSUN2</italic> than in other genes.</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Mutations of m<sup>5</sup>C writer and reader in GI cancer. <bold>(A)</bold> Alteration frequency of m<sup>5</sup>C regulatory factors in GI cancer, including mutations, amplification, and deletion, and multiple changes were analyzed from the TCGA database and studied in cBioPortal. About 28% (52/186) of esophageal cancer, 8% (14/186) of pancreatic cancer, 19% (91/478) of stomach cancer, 5% (33/640) of colorectal cancer, 13% (56/442) of liver cancer, and 12% (234/1,928) of GI cancer had genomic changes of m<sup>5</sup>C regulators. <bold>(B)</bold> The alteration frequency of m<sup>5</sup>C regulatory factors in gastrointestinal cancer from the TCGA database was analyzed in cBioPortal. The gene alteration frequencies of m<sup>5</sup>C regulators in GI cancer was 2.4% in <italic>NSUN1</italic>, 4% in <italic>NSUN2</italic>, 1.8% in <italic>NSUN5</italic>, and 2.2% in <italic>ALYREF</italic>, etc. <bold>(C)</bold> Protein structure alteration (missense, truncating, and inframe mutation) was analyzed in GI cancers.</p></caption><graphic xlink:href="fmolb-07-599340-g003"/></fig></sec><sec id="S3.SS3"><title>Impact of m<sup>5</sup>C Regulator Alterations on Patient Survival</title><p>Next, we used clinical information in the TCGA database to evaluate the influence of m<sup>5</sup>C writers and reader expression on the survival rate in patients with GI cancer. Kaplan&#x02013;Meier analysis showed that the differential expression of some m<sup>5</sup>C writers and reader was significantly related to overall survival (OS) (<xref ref-type="fig" rid="F4">Figure 4</xref> and <xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>). In this picture, we can find that except the <italic>NSUN7</italic> gene, the survival rates of other genes have significant differences in the different GI cancers. Among them, the <italic>P</italic> value of the <italic>NSUN5</italic> and <italic>ALYREF</italic> genes in colorectal cancer, liver cancer, and GC is less than 0.05, and the <italic>NSUN6</italic> gene also has significant differences in colorectal cancer, liver cancer, and PC. Remarkably, high expression of almost all m<sup>5</sup>C regulators was significantly associated with shorter OS in HCC patients. These results suggest that m<sup>5</sup>C regulators may play an important role in the survival of HCC patients.</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Kaplan&#x02013;Meier survival curves of m<sup>5</sup>C regulatory factors in GI cancer. Kaplan&#x02013;Meier survival curves were drawn based on the differential expression level of m<sup>5</sup>C regulatory factors in GI cancer. The red and green curves showed survival curves of the high and low expression groups, respectively. <sup>&#x02217;</sup><italic>P</italic> &#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup><italic>P</italic> &#x0003c; 0.01, and <sup>&#x02217;&#x02217;&#x02217;</sup><italic>P</italic> &#x0003c; 0.001 between the two groups.</p></caption><graphic xlink:href="fmolb-07-599340-g004"/></fig></sec><sec id="S3.SS4"><title>Association of m<sup>5</sup>C Regulators With Clinicopathological Parameters</title><p>We investigated the association of m<sup>5</sup>C regulator expression with gender (male and female), cancer status (tumor and normal), tumor grade (G1, G2, and G3), and pathological stage (stage I, stage II, stage III, and stage IV) as shown in <xref rid="T1" ref-type="table">Table 1</xref>. The results showed that the overall expression of m<sup>5</sup>C writers was significantly associated with pathological stage and tumor differentiation grade and the expression of m<sup>5</sup>C reader was significantly associated with gender, cancer status, and pathological stage. The association of respective m<sup>5</sup>C regulator with these parameters is shown in <xref ref-type="fig" rid="F5">Figure 5</xref>. The expression of <italic>ALYREF</italic> and <italic>NSUN6</italic> was significantly higher in female than in male patients. The level of <italic>NSUN3</italic> and <italic>NSUN6</italic> was increased in tumor samples, whereas the level of <italic>ALYREF</italic>, <italic>NSUN5</italic>, and <italic>NSUN7</italic> was decreased in tumor samples. For tumor grade, all m<sup>5</sup>C regulators gradually increased from G1 to G3 except <italic>NSUN6</italic>, which showed an opposite trend of expression. Similar to the result for tumor grade, the expression of all m<sup>5</sup>C regulators was elevated from pathological stage I to IV, except for <italic>NSUN6</italic> whose expression was lowered. We also performed the same analysis of the nine m<sup>5</sup>C writers and readers in different types of GI cancer and liver cancer separately (<xref ref-type="supplementary-material" rid="TS2">Supplementary Table S2</xref>).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Association of m<sup>5</sup>C mRNA expression with clinicopathological parameters of GI cancer patients.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" colspan="2" rowspan="1"/><td valign="top" align="center" colspan="4" rowspan="1">Writer<hr/></td><td valign="top" align="center" colspan="4" rowspan="1">Reader<hr/></td></tr><tr><td valign="top" colspan="2" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">&#x003c7; <sup>2</sup></td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic></td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">&#x003c7; <sup>2</sup></td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender</td><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">999</td><td valign="top" align="center" rowspan="1" colspan="1">50</td><td valign="top" align="center" rowspan="1" colspan="1">0.1591</td><td valign="top" align="center" rowspan="1" colspan="1">0.6900</td><td valign="top" align="center" rowspan="1" colspan="1">487</td><td valign="top" align="center" rowspan="1" colspan="1">562</td><td valign="top" align="center" rowspan="1" colspan="1">13.86</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0.0002</bold><sup>&#x02217;&#x02217;&#x02217;</sup></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">616</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">359</td><td valign="top" align="center" rowspan="1" colspan="1">285</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cancer status</td><td valign="top" align="left" rowspan="1" colspan="1">Tumor</td><td valign="top" align="center" rowspan="1" colspan="1">842</td><td valign="top" align="center" rowspan="1" colspan="1">48</td><td valign="top" align="center" rowspan="1" colspan="1">3.321</td><td valign="top" align="center" rowspan="1" colspan="1">0.0684</td><td valign="top" align="center" rowspan="1" colspan="1">397</td><td valign="top" align="center" rowspan="1" colspan="1">493</td><td valign="top" align="center" rowspan="1" colspan="1">26.22</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.0001</bold><sup>&#x02217;&#x02217;&#x02217;</sup></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="center" rowspan="1" colspan="1">573</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">345</td><td valign="top" align="center" rowspan="1" colspan="1">248</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Grade</td><td valign="top" align="left" rowspan="1" colspan="1">G1</td><td valign="top" align="center" rowspan="1" colspan="1">103</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">47</td><td valign="top" align="center" rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">G2</td><td valign="top" align="center" rowspan="1" colspan="1">438</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">22.57</td><td valign="top" align="center" rowspan="1" colspan="1">0.4798</td><td valign="top" align="center" rowspan="1" colspan="1">226</td><td valign="top" align="center" rowspan="1" colspan="1">226</td><td valign="top" align="center" rowspan="1" colspan="1">2.651</td><td valign="top" align="center" rowspan="1" colspan="1">0.4147</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">G3</td><td valign="top" align="center" rowspan="1" colspan="1">497</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">256</td><td valign="top" align="center" rowspan="1" colspan="1">260</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pathological stage</td><td valign="top" align="left" rowspan="1" colspan="1">Stage I</td><td valign="top" align="center" rowspan="1" colspan="1">334</td><td valign="top" align="center" rowspan="1" colspan="1">33</td><td valign="top" align="center" rowspan="1" colspan="1">8.508</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0.0366</bold><sup>&#x02217;</sup></td><td valign="top" align="center" rowspan="1" colspan="1">101</td><td valign="top" align="center" rowspan="1" colspan="1">266</td><td valign="top" align="center" rowspan="1" colspan="1">20.8</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0.0001</bold><sup>&#x02217;&#x02217;&#x02217;</sup></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Stage II</td><td valign="top" align="center" rowspan="1" colspan="1">580</td><td valign="top" align="center" rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">233</td><td valign="top" align="center" rowspan="1" colspan="1">410</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Stage III</td><td valign="top" align="center" rowspan="1" colspan="1">435</td><td valign="top" align="center" rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">175</td><td valign="top" align="center" rowspan="1" colspan="1">286</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Stage IV</td><td valign="top" align="center" rowspan="1" colspan="1">133</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">67</td><td valign="top" align="center" rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><attrib><italic>*P &#x0003c; 0.05, **P &#x0003c; 0.01, and ***P &#x0003c; 0.001.</italic></attrib></table-wrap-foot></table-wrap><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>Association of m<sup>5</sup>C regulator expression with clinicopathological parameters in GI cancer. Clinical parameter analysis includes stage of tumor differentiation (G1, G2, and G3), pathological stage, and cancer status, and gender was analyzed by one-way ANOVA.</p></caption><graphic xlink:href="fmolb-07-599340-g005"/></fig></sec><sec id="S3.SS5"><title>Pathways Associated With m<sup>5</sup>C Regulators</title><p>We further analyzed proteins that were altered upon m<sup>5</sup>C regulator mutation (mutation, amplification, and deep deletion). Since data were not found in liver cancer, subsequent analysis was done in other four types of GI cancer. Proteins that showed significant changes (<italic>P</italic> &#x0003c; 0.05) were shown in the volcano map (<xref ref-type="fig" rid="F6">Figure 6A</xref>). All the differential proteins were summarized in <xref ref-type="supplementary-material" rid="TS3">Supplementary Table S3</xref>. In order to know which pathway the differential proteins are enriched, we used DAVID for Kyoto Encyclopedia of Genes and Genomes (KEGG) proteins enrichment. According to the downstream gene count and <italic>P</italic> value, bubble plots were constructed in different types of GI cancer (<xref ref-type="fig" rid="F6">Figure 6B</xref>). The <italic>P</italic> value and the number of genes are shown in this figure. More detailed data can be found in <xref ref-type="supplementary-material" rid="TS3">Supplementary Tables S3</xref> and <xref ref-type="supplementary-material" rid="TS4">S4</xref>. In addition, a heat map was constructed (<xref ref-type="fig" rid="F6">Figure 6C</xref>) considering P values of different pathways. Among 34 pathways, we found some major pathways affected by m<sup>5</sup>C regulators: ErbB, PI3K&#x02013;Akt, HIF-1, and mTOR signaling pathways. Combining the bubble plots and heat map results, we conclude that the ErbB signaling pathway and PI3K&#x02013;Akt signaling pathway are the most important downstream pathways of m<sup>5</sup>C RNA methylation modification.</p><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>Main signaling pathways affected by m<sup>5</sup>C. <bold>(A)</bold> Volcano plot showing the proteins significantly affected by m<sup>5</sup>C regulators mutation in GI cancer. -log<sub>10</sub> (<italic>P</italic> value) &#x0003e;1.30 was considered a significant change. <bold>(B)</bold> Bubble plots showing the downstream pathways of m<sup>5</sup>C based on gene count and <italic>P</italic> value. Prediction of the downstream pathways related to m<sup>5</sup>C gene alterations was analyzed by KEGG pathway analysis <italic>via</italic> DAVID. <bold>(C)</bold> Heat map showing the important downstream pathways of m<sup>5</sup>C in GI cancers based on <italic>P</italic> value.</p></caption><graphic xlink:href="fmolb-07-599340-g006"/></fig></sec><sec id="S3.SS6"><title>Function and Interaction of Downstream Pathway Proteins</title><p>We analyzed the 54 differential proteins (<xref ref-type="supplementary-material" rid="TS3">Supplementary Table S3</xref>) that were enriched in the ErbB and PI3K&#x02013;Akt signaling pathways by GO terms biological process enriched <italic>via</italic> DAVID. The result demonstrated that these proteins were mainly involved in the regulation of protein binding, cytosol, and signal transduction (<xref ref-type="fig" rid="F7">Figure 7A</xref>). To further understand the interaction between these differential proteins and m<sup>5</sup>C regulators, we mapped protein&#x02013;protein interaction (PPI) networks. The results showed that <italic>ALYREF</italic> and <italic>RPS6</italic> were important connections between differential proteins and m<sup>5</sup>C regulators (<xref ref-type="fig" rid="F7">Figure 7B</xref>).</p><fig id="F7" position="float"><label>FIGURE 7</label><caption><p>GO and network analysis of proteins in two important pathways. <bold>(A)</bold> Gene Ontology (GO) enrichment analysis of the m<sup>5</sup>C RNA methylation modification was analyzed <italic>via</italic> DAVID. GO contains biological processes, cell components, and molecular functions. In this picture, count represents the number of genes contained in the GO term. The count and <italic>P</italic> values were considered together to obtain important metabolic process. Three important metabolic processes are affected by m<sup>5</sup>C RNA methylation, including protein binding, cytosol, and signal transduction. <bold>(B)</bold> Multicenter protein&#x02013;protein interaction (PPI) network between m<sup>5</sup>C regulatory proteins and differential proteins in the ErbB and PI3K&#x02013;Akt pathways in the STRING database.</p></caption><graphic xlink:href="fmolb-07-599340-g007"/></fig></sec><sec id="S3.SS7"><title><italic>GSK3B</italic> Is Closely Related to m<sup>5</sup>C Regulators</title><p>In order to determine the importance of functional annotations between different proteins, we conducted analysis by using the R/Bioconductor package GOSemSim. According to the ranking results of importance, the results showed that among downstream pathway-associated proteins, <italic>GSK3B</italic> plays a crucial role in the three major categories of GO, including biological processes, cell components, and molecular functions. Other important proteins included AKT1S1, RAF1, ERBB2, SRC, MAPK3, MAP2K1, BRAF, AKT1, and MAPK1 (<xref ref-type="fig" rid="F8">Figure 8A</xref>). Next, we used the expression level of these genes to map the correlation between them. The results showed that <italic>GSK3B</italic> was positively correlated with most genes (<xref ref-type="fig" rid="F8">Figure 8B</xref>). Then, we analyzed the correlation of GSK3B with m<sup>5</sup>C regulators (<xref ref-type="fig" rid="F8">Figure 8C</xref>). The result showed that <italic>GSK3B</italic> was significantly and positively correlated with all m<sup>5</sup>C regulators except for <italic>NSUN6</italic> for which it showed negative correlation, indicating that <italic>GSK3B</italic> protein may be closely related to m<sup>5</sup>C writer and reader. In the human disease methylation database (DiseaseMeth version 2.0), we found that <italic>GSK3B</italic> is not influenced by DNA methylation in GI cancer (<xref ref-type="supplementary-material" rid="FS2">Supplementary Figure S2</xref>). In conclusion, we believe that m<sup>5</sup>C writer and reader mainly affect genes in the ErbB/PI3K&#x02013;Akt signaling pathway, and that <italic>GSK3B</italic> may be an important downstream target of m<sup>5</sup>C regulators.</p><fig id="F8" position="float"><label>FIGURE 8</label><caption><p>GSK3B is closely related to m<sup>5</sup>C regulators. <bold>(A)</bold> The importance of key proteins of the downstream pathway in the three major categories of Gene Ontology (GO), including biological processes, cell components, and molecular functions. The <italic>X</italic> axis is the score obtained by comprehensively considering the weight of the three categories of GO. The higher the score, the more important the protein is involved in the GO project. <bold>(B)</bold> Co-expression analysis of m<sup>5</sup>C differential proteins of the ErbB and PI3K&#x02013;Akt pathways. The co-expression scores of related genes were displayed. The color intensity reflects the reliability of co-expression; meanwhile, red and blue indicate high correlation and low correlation, respectively. <bold>(C)</bold> Correlation analysis between writers and reader protein of m<sup>5</sup>C with <italic>GSK3B</italic>. There were significant differences between GSK3B and all genes. <bold>(D)</bold> The samples were grouped according to the median expression of GSK3B gene, and differential expression analysis was performed. <bold>(E)</bold> 3D structure of streptozotocin. <bold>(F)</bold> PPI network analysis between the common genes between streptozotocin.</p></caption><graphic xlink:href="fmolb-07-599340-g008"/></fig></sec><sec id="S3.SS8"><title>Network Pharmacology Analysis of the <italic>GSK3B</italic> Gene in GI Cancer</title><p>The transcriptome data of GI cancer were integrated, and tumor samples were divided into the high and low expression groups according to the median level of the <italic>GSK3B</italic> gene expression. In total, 2,071 significantly up-regulated and 695 significantly down-regulated genes were identified (<xref ref-type="fig" rid="F8">Figure 8D</xref>). In order to find the probable drug targeting the <italic>GSK3B</italic> gene <italic>via</italic> the CMap database, we screened the first 150 genes in the up-regulated and down-regulated genes, respectively. Streptozotocin was the highest score in the prediction. Next, the PubChem database was applied to obtain the 3D structure of streptozotocin (<xref ref-type="fig" rid="F8">Figure 8E</xref>). Next, 280 target genes were gained through the PharmMapper database. Then, we chose the common genes between 274 drug targets and 2,766 differential genes of the <italic>GSK3B</italic> gene, and finally, 29 genes were used for PPI network with this compound on streptozotocin, including <italic>HUWE1</italic>, <italic>AGT</italic>, <italic>HAO1</italic>, <italic>CPB2</italic>, <italic>WNK1</italic>, <italic>CPA4</italic>, <italic>ZNF462</italic>, <italic>RIMS2</italic>, <italic>GAS2</italic>, <italic>CFTR</italic>, <italic>PLA2G1B</italic>, <italic>F2</italic>, <italic>SERPINC1</italic>, <italic>TRIO</italic>, <italic>FAH</italic>, <italic>CSNK1G1</italic>, <italic>AGO2</italic>, <italic>PRC1</italic>, <italic>ASIC1</italic>, <italic>CYB5A</italic>, <italic>GTF2I</italic>, <italic>IL10</italic>, <italic>IGFBP1</italic>, <italic>SDK2</italic>, <italic>GAMT</italic>, <italic>LDHB</italic>, <italic>ALB</italic>, <italic>NUDT4</italic>, and <italic>IGF2BP2</italic> (<xref ref-type="fig" rid="F8">Figure 8F</xref>).</p></sec></sec><sec id="S4"><title>Discussion</title><p>5-Methylcytosine modifications of RNA are ubiquitous in nature and play important roles in many biological processes, such as protein translational regulation, RNA processing, and stress response (<xref rid="B18" ref-type="bibr">Hussain et al., 2013</xref>; <xref rid="B75" ref-type="bibr">Yuan et al., 2014</xref>; <xref rid="B35" ref-type="bibr">Liu et al., 2017</xref>); RNA stability (<xref rid="B59" ref-type="bibr">Tuorto et al., 2012</xref>; <xref rid="B78" ref-type="bibr">Zhang et al., 2012</xref>); RNA transport (<xref rid="B71" ref-type="bibr">Yang X. et al., 2017</xref>); and mRNA translation (<xref rid="B53" ref-type="bibr">Tang et al., 2015</xref>; <xref rid="B69" ref-type="bibr">Xing et al., 2015</xref>; <xref rid="B51" ref-type="bibr">Sun et al., 2019</xref>). Currently, the modification mechanism of m<sup>5</sup>C in cancer is being explored. Nonetheless, the exact catalytic mechanism of m<sup>5</sup>C methylation remained unclear (<xref rid="B31" ref-type="bibr">Li Q. et al., 2017</xref>; <xref rid="B35" ref-type="bibr">Liu et al., 2017</xref>; <xref rid="B58" ref-type="bibr">Trixl and Lusser, 2019</xref>). Herein, we conducted a comprehensive analysis of known m<sup>5</sup>C writers (<italic>NSUN1-7</italic> and <italic>TRDMT1</italic>) and reader (<italic>ALYREF</italic>) in GI cancer. Overall, the expression level of m<sup>5</sup>C regulators was distinctly different across all samples (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Notably, the expression of <italic>NSUN1</italic>, <italic>NSUN3</italic>, <italic>NSUN4</italic>, <italic>NSUN5</italic>, and <italic>ALYREF</italic> was all significantly elevated in GI cancer (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Meanwhile, the genomic and protein structure alterations of m<sup>5</sup>C regulators were also determined (<xref ref-type="fig" rid="F3">Figure 3</xref>). Overall, the mutation rate of m<sup>5</sup>C regulators in GI cancer was not high, and it was relatively higher in esophagus and stomach cancers than in other cancers (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). The mutation rate for <italic>NSUN2</italic> was the highest. In accordance with our finding, copy number gain of <italic>NSUN2</italic> has been reported in breast, oral, and colorectal cancers (<xref rid="B12" ref-type="bibr">Frye et al., 2010</xref>; <xref rid="B43" ref-type="bibr">Okamoto et al., 2012</xref>), which leads to the increased expression of it in cancers. Alteration in protein structure was seen in all m<sup>5</sup>C regulators (<xref ref-type="fig" rid="F3">Figure 3C</xref>). There were more protein alteration sites in <italic>NSUN1</italic> and <italic>NSUN2</italic> than in other regulators, whereas there was only one alteration site in <italic>ALYREF</italic>. Although study on the role of m<sup>5</sup>C regulatory proteins in cancer was very limited, <italic>NSUN2</italic> was relatively well-studied among m<sup>5</sup>C regulators. There were a few reports on the elevated expression of <italic>NSUN2</italic> in a range of cancer, including oral (<xref rid="B43" ref-type="bibr">Okamoto et al., 2012</xref>), head and neck (<xref rid="B37" ref-type="bibr">Lu et al., 2018</xref>), colorectal (<xref rid="B43" ref-type="bibr">Okamoto et al., 2012</xref>), breast (<xref rid="B12" ref-type="bibr">Frye et al., 2010</xref>; <xref rid="B72" ref-type="bibr">Yi et al., 2017</xref>), ovarian (<xref rid="B70" ref-type="bibr">Yang J. C. et al., 2017</xref>), and GI cancers (<xref rid="B43" ref-type="bibr">Okamoto et al., 2012</xref>), which was consistent with our bioinformatics analysis. <italic>TDMT1</italic>/<italic>DNMT2</italic>, a member of DNA methyltransferases, was shown to be down-regulated in liver (<xref rid="B44" ref-type="bibr">Saito et al., 2001</xref>), stomach, and colorectal cancers (<xref rid="B23" ref-type="bibr">Kanai et al., 2001</xref>). In contrast, it was significantly over-expressed in stomach and liver cancers from our study and decreased in PC (<xref ref-type="fig" rid="F2">Figure 2B</xref>).</p><p>Next, we used clinical information to evaluate the association of m<sup>5</sup>C regulator expression with patient survival and clinicopathological parameters. Notably, high expression of almost all m<sup>5</sup>C regulators was significantly associated with shorter OS in HCC patients except <italic>NSUN7</italic>, indicating that dysregulation of m<sup>5</sup>C regulators may strongly influence liver cancer patient survival (<xref ref-type="fig" rid="F4">Figure 4</xref> and <xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>). High expression of <italic>NSUN2</italic> has been reported to predict poor survival in head and neck cancer (<xref rid="B37" ref-type="bibr">Lu et al., 2018</xref>). It was only found to be associated with shorter survival in liver cancer from our study. For clinicopathological parameters, consistent with previous result (<xref ref-type="fig" rid="F2">Figure 2B</xref>), the level of <italic>NSUN3</italic> and <italic>NSUN6</italic> was increased in tumor samples versus normal samples (<xref ref-type="fig" rid="F5">Figure 5</xref>). For tumor grade, the expression of m<sup>5</sup>C regulators increased from G1 to G3 except <italic>NSUN6</italic>, which showed an opposite trend of expression. The result for pathological grade was similar to that for tumor grade. The expression of all m<sup>5</sup>C regulators was elevated from pathological stage I to IV, except for <italic>NSUN6</italic> whose expression was decreased (<xref ref-type="fig" rid="F5">Figure 5</xref>). Similar to our result, <italic>NSUN2</italic> has been found to be significantly correlated with clinical stage and pathological differentiation in breast cancer (<xref rid="B72" ref-type="bibr">Yi et al., 2017</xref>).</p><p>In an attempt to find out the major targets or pathways modulated by m<sup>5</sup>C regulators, we first determined proteins that were significantly altered upon m<sup>5</sup>C regulator gene alteration. The results demonstrated that alteration in m<sup>5</sup>C regulators led to the decreased expression of oncogenic YAP1 and RICTOR and increased expression of DNA mismatch repair proteins MSH2 and MSH6 (<xref ref-type="fig" rid="F6">Figure 6A</xref>). We then further determined which signaling pathways these differential proteins mainly belong to. By taking the gene count and P value into account, we found that PI3K&#x02013;Akt and ErbB were the most important pathways affected by m<sup>5</sup>C regulators among other pathways including the mTOR and HIF-1 pathways (<xref ref-type="fig" rid="F6">Figures 6B,C</xref>). The differential proteins in the PI3K&#x02013;Akt and ErbB pathways play important roles in regulating protein binding, cytosol, and signal transduction from GO analysis (<xref ref-type="fig" rid="F7">Figure 7A</xref>). The PI3K&#x02013;Akt and ErbB pathways are important cancer-related pathways. Studies have shown that the ErbB signaling pathway is regulated by miR-200a/141 in the epithelial&#x02013;mesenchymal transition (EMT)-related microRNA-200 family in renal cell carcinoma (RCC) (<xref rid="B73" ref-type="bibr">Yoshino et al., 2013</xref>). At the same time, accumulating evidence has elucidated that the PI3K&#x02013;Akt signaling pathway is highly activated (<xref rid="B14" ref-type="bibr">Guo et al., 2015</xref>; <xref rid="B16" ref-type="bibr">Hao et al., 2019</xref>) and is a validated therapeutic target in RCC (<xref rid="B33" ref-type="bibr">Lin et al., 2014</xref>). Key miRNAs and target genes have been reported to be mainly related to the PI3K&#x02013;Akt signaling pathway in GI cancers (<xref rid="B26" ref-type="bibr">Lai et al., 2019</xref>). A bioinformatics analysis showed that the DEGs of EC compared with normal tissues are mainly enriched in the PI3K&#x02013;Akt signaling pathway (<xref rid="B30" ref-type="bibr">Li M. et al., 2020</xref>; <xref rid="B76" ref-type="bibr">Yu-Jing et al., 2020</xref>). Moreover, GLI1 co-expressed and DEGs between tumor samples and normal tissues were both largely enriched in the PI3K&#x02013;Akt pathway in STAD (<xref rid="B74" ref-type="bibr">Yu et al., 2018</xref>; <xref rid="B29" ref-type="bibr">Li et al., 2019</xref>). In PAAD, 4-miRNA as independent prognostic factor was found to be related to the PI3K&#x02013;Akt signaling pathway (<xref rid="B66" ref-type="bibr">Wang et al., 2019</xref>). Growing evidence revealed that the ErbB and PI3K&#x02013;Akt signaling pathways play vital roles in colorectal cancer by regulating microRNA, lncRNA, mRNA, etc. (<xref rid="B52" ref-type="bibr">Szmida et al., 2015</xref>; <xref rid="B48" ref-type="bibr">Song et al., 2018</xref>; <xref rid="B67" ref-type="bibr">Wei et al., 2019</xref>; <xref rid="B79" ref-type="bibr">Zhong et al., 2019</xref>; <xref rid="B62" ref-type="bibr">Wan et al., 2020</xref>). These findings indicate that GI cancer is closely related to the ErbB and PI3K&#x02013;Akt signaling pathways. By visualizing the PPI network of m<sup>5</sup>C regulators and their potential downstream targets in the PI3K&#x02013;Akt and ErbB pathways, we found that m<sup>5</sup>C regulators formed a group and were closely connected with the differential protein group by NOP2, ALYREF, and RPS6 (<xref ref-type="fig" rid="F7">Figure 7B</xref>).</p><p>Further analysis revealed that <italic>GSK3B</italic> was an important potential target for m<sup>5</sup>C regulators (<xref ref-type="fig" rid="F8">Figure 8</xref>). It showed strong association with m<sup>5</sup>C regulators (<xref ref-type="fig" rid="F8">Figure 8B</xref>) and differential proteins and was also important in GO biological processes (<xref ref-type="fig" rid="F8">Figure 8A</xref>). Importantly, <italic>GSK3B</italic> was significantly and positively associated with nearly all m<sup>5</sup>C regulators, whereas it was negatively correlated with NSUN6, indicating that it probably is a downstream target of m<sup>5</sup>C regulators (<xref ref-type="fig" rid="F8">Figure 8C</xref>). In order to further explore the targeted drugs of the <italic>GSK3B</italic> gene in GI cancer, we divided the tumor samples into two groups based on the median GSK3B expression level for differential expression analysis (<xref ref-type="fig" rid="F8">Figure 8D</xref>). The first 150 genes were selected from the significantly up-regulated and down-regulated differential genes, respectively, for potential drug target analysis. The results showed that streptozotocin (P-selectin inhibitor) was used for further analysis with the highest score of 96.16 (<xref ref-type="fig" rid="F8">Figure 8E</xref>). Next, the targeted gene of the compound on streptozotocin was identified <italic>via</italic> the PharmMapper database, then we found 29 common genes of the gene target and GSK3B differential genes, and PPI network was used to display the relationship of 29 genes and the streptozotocin (<xref ref-type="fig" rid="F8">Figure 8F</xref>). <italic>GSK3B</italic> has been shown to be frequently up-regulated in many types of cancer (<xref rid="B9" ref-type="bibr">Darrington et al., 2012</xref>; T. <xref rid="B77" ref-type="bibr">Zhang et al., 2019</xref>), and inhibition of it was considered efficient in suppressing tumor growth (<xref rid="B11" ref-type="bibr">Edderkaoui et al., 2018</xref>; <xref rid="B68" ref-type="bibr">Wu et al., 2019</xref>). Moreover, there have been many studies on GSK3B inhibitors, including Metavert molecule in PAAD (<xref rid="B11" ref-type="bibr">Edderkaoui et al., 2018</xref>), BT-000775 molecule in BRCA (<xref rid="B42" ref-type="bibr">Ogunleye et al., 2019</xref>), BIO molecule in TNBCs (triple-negative breast cancers) (<xref rid="B61" ref-type="bibr">Vijay et al., 2019</xref>), AR-A014418 and SB-216763 molecules in STSs (soft tissue sarcomas) (<xref rid="B2" ref-type="bibr">Abe et al., 2020</xref>), etc.</p><p>In summary, our study demonstrated for the first time the comprehensive analysis of m<sup>5</sup>C modulators in GI cancer. The dysregulation of m<sup>5</sup>C regulators in GI cancer was shown, its association with patient survival and clinicopathological parameters were analyzed, and the main downstream pathway and major target were determined. Besides, the compound termed streptozotocin may be a key candidate drug for targeted therapy in GI cancer. This is a pioneer study of the relationship between m<sup>5</sup>C dysregulation and cancer, but our results lack experimental verification, which warrants further validation of the involvement of m<sup>5</sup>C regulators and their downstream targets in GI cancer.</p></sec><sec sec-type="data-availability" id="S5"><title>Data Availability Statement</title><p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="FS1">Supplementary Material</xref>, further inquiries can be directed to the corresponding author/s.</p></sec><sec id="S6"><title>Author Contributions</title><p>SX, YM, and QW analyzed the data and wrote the manuscript. JS, ZX, and QW provided funding. YSZ, XW, and ML designed the study. PK and YZ prepared and adjusted the figures. XY, XL, and JL reviewed and revised the manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (Grant nos. 81602166 and 81672444) and Sichuan Science and Technology Plan Project (2018JY0079).</p></fn></fn-group><fn-group><fn id="footnote1"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="http://cancergenome.nih.gov">http://cancergenome.nih.gov</ext-link></p></fn><fn id="footnote2"><label>2</label><p><ext-link ext-link-type="uri" xlink:href="https://xenabrowser.net/">https://xenabrowser.net/</ext-link></p></fn><fn id="footnote3"><label>3</label><p><ext-link ext-link-type="uri" xlink:href="http://www.cbioportal.org/">http://www.cbioportal.org/</ext-link></p></fn><fn id="footnote4"><label>4</label><p><ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov">https://david.ncifcrf.gov</ext-link></p></fn></fn-group><sec id="S8" sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2020.599340/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2020.599340/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="FS1"><label>Supplementary Figure 1</label><caption><p>PCA analysis of GI cancer. Principal component analysis of liver cancer, colorectal cancer, gastric cancer, pancreatic cancer, and esophageal cancer according to genes expression level. <italic>N</italic> = 1,695 data points. <italic>X</italic> and <italic>Y</italic> axes show principal component 1 and principal component 2 that explain 39.5 and 16.4% of the total variance, respectively. Prediction ellipses are such that with probability 0.95, a new observation from the same group will fall inside the ellipse. The further apart the two samples are, the greater the difference in genetic background between them will be.</p></caption><media xlink:href="Image_1.JPEG"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS2"><label>Supplementary Figure 2</label><caption><p>DNA methylation analysis of differential genes in GI cancer. DNA methylation analysis of key downstream pathways in GI cancer. The darker the blue, the lower the DNA methylation, and the darker the red, the higher the DNA methylation.</p></caption><media xlink:href="Image_2.JPEG"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS1"><label>Supplementary Table 1</label><caption><p>Survival curve data of m<sup>5</sup>C writer and reader in GI cancer.</p></caption><media xlink:href="Table_1.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS2"><label>Supplementary Table 2</label><caption><p>The data of Chi-square analysis on cancer status (tumor and normal), pathological stage (stage I, stage II, stage III, and stage IV), gender (male and female), and tumor differentiation (G1, G2, and G3) in different types of GI cancer and liver cancer separately.</p></caption><media xlink:href="Table_2.XLS"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS3"><label>Supplementary Table 3</label><caption><p>Differential proteins in important pathways.</p></caption><media xlink:href="Table_3.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS4"><label>Supplementary Table 4</label><caption><p>The data of different pathways in GI cancer.</p></caption><media xlink:href="Table_4.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi-Moheb</surname><given-names>L.</given-names></name><name><surname>Mertel</surname><given-names>S.</given-names></name><name><surname>Gonsior</surname><given-names>M.</given-names></name><name><surname>Nouri-Vahid</surname><given-names>L.</given-names></name><name><surname>Kahrizi</surname><given-names>K.</given-names></name><name><surname>Cirak</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Mutations in NSUN2 cause autosomal-recessive intellectual disability.</article-title>
<source><italic>Am. J. Hum. Genet.</italic></source>
<volume>90</volume>
<fpage>847</fpage>&#x02013;<lpage>855</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.03.021</pub-id>
<?supplied-pmid 22541559?><pub-id pub-id-type="pmid">22541559</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Domoto</surname><given-names>T.</given-names></name><name><surname>Bolidong</surname><given-names>D.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Takeuchi</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Glycogen synthase kinase 3beta as a potential therapeutic target in synovial sarcoma and fibrosarcoma.</article-title>
<source><italic>Cancer Sci.</italic></source>
<volume>111</volume>
<fpage>429</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1111/cas.14271</pub-id>
<?supplied-pmid 31808966?><pub-id pub-id-type="pmid">31808966</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aslan</surname><given-names>A.</given-names></name><name><surname>Vrabiescu</surname><given-names>A.</given-names></name><name><surname>Busila</surname><given-names>V.</given-names></name></person-group> (<year>1967</year>). <article-title>[Studies of peripheral circulation with the postural oscillometric method in a group of aged persons treated with potentiated Gerovital H].</article-title>
<source><italic>Fiziol. Norm. Patol.</italic></source>
<volume>13</volume>
<fpage>561</fpage>&#x02013;<lpage>566</lpage>.<pub-id pub-id-type="pmid">5594206</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilgin</surname><given-names>B.</given-names></name><name><surname>Sendur</surname><given-names>M. A.</given-names></name><name><surname>Bulent Akinci</surname><given-names>M.</given-names></name><name><surname>Sener Dede</surname><given-names>D.</given-names></name><name><surname>Yalcin</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.</article-title>
<source><italic>Curr. Med. Res. Opin.</italic></source>
<volume>33</volume>
<fpage>749</fpage>&#x02013;<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1080/03007995.2017.1279132</pub-id>
<?supplied-pmid 28055269?><pub-id pub-id-type="pmid">28055269</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>S.</given-names></name><name><surname>Bandiera</surname><given-names>R.</given-names></name><name><surname>Popis</surname><given-names>M.</given-names></name><name><surname>Hussain</surname><given-names>S.</given-names></name><name><surname>Lombard</surname><given-names>P.</given-names></name><name><surname>Aleksic</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Stem cell function and stress response are controlled by protein synthesis.</article-title>
<source><italic>Nature</italic></source>
<volume>534</volume>
<fpage>335</fpage>&#x02013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1038/nature18282</pub-id>
<?supplied-pmid 27306184?><pub-id pub-id-type="pmid">27306184</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Pang</surname><given-names>L.</given-names></name><name><surname>Xing</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>RNA methyltransferase NSUN2 promotes stress-induced HUVEC senescence.</article-title>
<source><italic>Oncotarget</italic></source>
<volume>7</volume>
<fpage>19099</fpage>&#x02013;<lpage>19110</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.8087</pub-id>
<?supplied-pmid 26992231?><pub-id pub-id-type="pmid">26992231</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerami</surname><given-names>E.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Dogrusoz</surname><given-names>U.</given-names></name><name><surname>Gross</surname><given-names>B. E.</given-names></name><name><surname>Sumer</surname><given-names>S. O.</given-names></name><name><surname>Aksoy</surname><given-names>B. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.</article-title>
<source><italic>Cancer Discov.</italic></source>
<volume>2</volume>
<fpage>401</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0095</pub-id>
<?supplied-pmid 22588877?><pub-id pub-id-type="pmid">22588877</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>B. K. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Data analysis using r programming.</article-title>
<source><italic>Adv. Exp. Med. Biol.</italic></source>
<volume>1082</volume>
<fpage>47</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-93791-5_2</pub-id><pub-id pub-id-type="pmid">30357717</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darrington</surname><given-names>R. S.</given-names></name><name><surname>Campa</surname><given-names>V. M.</given-names></name><name><surname>Walker</surname><given-names>M. M.</given-names></name><name><surname>Bengoa-Vergniory</surname><given-names>N.</given-names></name><name><surname>Gorrono-Etxebarria</surname><given-names>I.</given-names></name><name><surname>Uysal-Onganer</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Distinct expression and activity of GSK-3alpha and GSK-3beta in prostate cancer.</article-title>
<source><italic>Int. J. Cancer</italic></source>
<volume>131</volume>
<fpage>E872</fpage>&#x02013;<lpage>E883</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.27620</pub-id>
<?supplied-pmid 22539113?><pub-id pub-id-type="pmid">22539113</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>G.</given-names><suffix>Jr.</suffix></name><name><surname>Sherman</surname><given-names>B. T.</given-names></name><name><surname>Hosack</surname><given-names>D. A.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Lane</surname><given-names>H. C.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>DAVID: database for annotation, visualization, and integrated discovery.</article-title>
<source><italic>Genome Biol.</italic></source>
<volume>4</volume>:<issue>3</issue>.</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edderkaoui</surname><given-names>M.</given-names></name><name><surname>Chheda</surname><given-names>C.</given-names></name><name><surname>Soufi</surname><given-names>B.</given-names></name><name><surname>Zayou</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>R. W.</given-names></name><name><surname>Ramanujan</surname><given-names>V. K.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>An Inhibitor of GSK3B and HDACs kills pancreatic cancer cells and slows pancreatic tumor growth and metastasis in mice.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>155</volume>
<fpage>1985.e5</fpage>&#x02013;<lpage>1998.e5</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2018.08.028</pub-id>
<?supplied-pmid 30144430?><pub-id pub-id-type="pmid">30144430</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>M.</given-names></name><name><surname>Dragoni</surname><given-names>I.</given-names></name><name><surname>Chin</surname><given-names>S. F.</given-names></name><name><surname>Spiteri</surname><given-names>I.</given-names></name><name><surname>Kurowski</surname><given-names>A.</given-names></name><name><surname>Provenzano</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer.</article-title>
<source><italic>Cancer Lett.</italic></source>
<volume>289</volume>
<fpage>71</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2009.08.004</pub-id>
<?supplied-pmid 19740597?><pub-id pub-id-type="pmid">19740597</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Aksoy</surname><given-names>B. A.</given-names></name><name><surname>Dogrusoz</surname><given-names>U.</given-names></name><name><surname>Dresdner</surname><given-names>G.</given-names></name><name><surname>Gross</surname><given-names>B.</given-names></name><name><surname>Sumer</surname><given-names>S. O.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.</article-title>
<source><italic>Sci. Signal.</italic></source>
<volume>6</volume>:<issue>l1</issue>. <pub-id pub-id-type="doi">10.1126/scisignal.2004088</pub-id>
<?supplied-pmid 23550210?><pub-id pub-id-type="pmid">23550210</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>German</surname><given-names>P.</given-names></name><name><surname>Bai</surname><given-names>S.</given-names></name><name><surname>Barnes</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The PI3K/AKT pathway and renal cell carcinoma.</article-title>
<source><italic>J. Genet. Genomics</italic></source>
<volume>42</volume>
<fpage>343</fpage>&#x02013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgg.2015.03.003</pub-id>
<?supplied-pmid 26233890?><pub-id pub-id-type="pmid">26233890</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haag</surname><given-names>S.</given-names></name><name><surname>Warda</surname><given-names>A. S.</given-names></name><name><surname>Kretschmer</surname><given-names>J.</given-names></name><name><surname>Gunnigmann</surname><given-names>M. A.</given-names></name><name><surname>Hobartner</surname><given-names>C.</given-names></name><name><surname>Bohnsack</surname><given-names>M. T.</given-names></name></person-group> (<year>2015</year>). <article-title>NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs.</article-title>
<source><italic>RNA</italic></source>
<volume>21</volume>
<fpage>1532</fpage>&#x02013;<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1261/rna.051524.115</pub-id>
<?supplied-pmid 26160102?><pub-id pub-id-type="pmid">26160102</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>P.</given-names></name><name><surname>Kang</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>W.</given-names></name><name><surname>Ma</surname><given-names>F.</given-names></name></person-group> (<year>2019</year>). <article-title>UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.</article-title>
<source><italic>Mol. Med. Rep.</italic></source>
<volume>20</volume>
<fpage>1212</fpage>&#x02013;<lpage>1220</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2019.10322</pub-id>
<?supplied-pmid 31173226?><pub-id pub-id-type="pmid">31173226</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Chung</surname><given-names>I. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Telomerase activates transcription of cyclin D1 gene through an interaction with NOL1.</article-title>
<source><italic>J. Cell. Sci.</italic></source>
<volume>129</volume>
<fpage>1566</fpage>&#x02013;<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.181040</pub-id>
<?supplied-pmid 26906424?><pub-id pub-id-type="pmid">26906424</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>S.</given-names></name><name><surname>Sajini</surname><given-names>A. A.</given-names></name><name><surname>Blanco</surname><given-names>S.</given-names></name><name><surname>Dietmann</surname><given-names>S.</given-names></name><name><surname>Lombard</surname><given-names>P.</given-names></name><name><surname>Sugimoto</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs.</article-title>
<source><italic>Cell. Rep.</italic></source>
<volume>4</volume>
<fpage>255</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.029</pub-id>
<?supplied-pmid 23871666?><pub-id pub-id-type="pmid">23871666</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>R.</given-names></name><name><surname>Zander</surname><given-names>S.</given-names></name><name><surname>Gutschner</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>The dark side of the epitranscriptome: chemical modifications in long non-coding RNAs.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>18</volume>:<issue>2387</issue>. <pub-id pub-id-type="doi">10.3390/ijms18112387</pub-id>
<?supplied-pmid 29125541?><pub-id pub-id-type="pmid">29125541</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeltsch</surname><given-names>A.</given-names></name><name><surname>Ehrenhofer-Murray</surname><given-names>A.</given-names></name><name><surname>Jurkowski</surname><given-names>T. P.</given-names></name><name><surname>Lyko</surname><given-names>F.</given-names></name><name><surname>Reuter</surname><given-names>G.</given-names></name><name><surname>Ankri</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Mechanism and biological role of Dnmt2 in nucleic acid methylation.</article-title>
<source><italic>RNA Biol.</italic></source>
<volume>14</volume>
<fpage>1108</fpage>&#x02013;<lpage>1123</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2016.1191737</pub-id>
<?supplied-pmid 27232191?><pub-id pub-id-type="pmid">27232191</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>L. J.</given-names></name><name><surname>Kuhn</surname><given-names>M.</given-names></name><name><surname>Stark</surname><given-names>M.</given-names></name><name><surname>Chaffron</surname><given-names>S.</given-names></name><name><surname>Creevey</surname><given-names>C.</given-names></name><name><surname>Muller</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>STRING 8&#x02013;a global view on proteins and their functional interactions in 630 organisms.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>37</volume>
<fpage>D412</fpage>&#x02013;<lpage>D416</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn760</pub-id>
<?supplied-pmid 18940858?><pub-id pub-id-type="pmid">18940858</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonkhout</surname><given-names>N.</given-names></name><name><surname>Tran</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name><name><surname>Schonrock</surname><given-names>N.</given-names></name><name><surname>Mattick</surname><given-names>J. S.</given-names></name><name><surname>Novoa</surname><given-names>E. M.</given-names></name></person-group> (<year>2017</year>). <article-title>The RNA modification landscape in human disease.</article-title>
<source><italic>RNA</italic></source>
<volume>23</volume>
<fpage>1754</fpage>&#x02013;<lpage>1769</lpage>. <pub-id pub-id-type="doi">10.1261/rna.063503.117</pub-id>
<?supplied-pmid 28855326?><pub-id pub-id-type="pmid">28855326</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanai</surname><given-names>Y.</given-names></name><name><surname>Ushijima</surname><given-names>S.</given-names></name><name><surname>Kondo</surname><given-names>Y.</given-names></name><name><surname>Nakanishi</surname><given-names>Y.</given-names></name><name><surname>Hirohashi</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers.</article-title>
<source><italic>Int. J. Cancer</italic></source>
<volume>91</volume>
<fpage>205</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1002/1097-0215(200002)9999:9999&#x0003c;::aid-ijc1040&#x0003e;3.0.co;2-2</pub-id><pub-id pub-id-type="pmid">11146446</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosronezhad</surname><given-names>N.</given-names></name><name><surname>Hosseinzadeh Colagar</surname><given-names>A.</given-names></name><name><surname>Mortazavi</surname><given-names>S. M.</given-names></name></person-group> (<year>2015</year>). <article-title>The Nsun7 (A11337)-deletion mutation, causes reduction of its protein rate and associated with sperm motility defect in infertile men.</article-title>
<source><italic>J. Assist. Reprod. Genet.</italic></source>
<volume>32</volume>
<fpage>807</fpage>&#x02013;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-015-0443-0</pub-id>
<?supplied-pmid 25702163?><pub-id pub-id-type="pmid">25702163</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosi</surname><given-names>N.</given-names></name><name><surname>Alic</surname><given-names>I.</given-names></name><name><surname>Kolacevic</surname><given-names>M.</given-names></name><name><surname>Vrsaljko</surname><given-names>N.</given-names></name><name><surname>Jovanov Milosevic</surname><given-names>N.</given-names></name><name><surname>Sobol</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Nop2 is expressed during proliferation of neural stem cells and in adult mouse and human brain.</article-title>
<source><italic>Brain Res.</italic></source>
<volume>1597</volume>
<fpage>65</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.11.040</pub-id>
<?supplied-pmid 25481415?><pub-id pub-id-type="pmid">25481415</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>C. H.</given-names></name><name><surname>Liang</surname><given-names>X. Z.</given-names></name><name><surname>Liang</surname><given-names>X. Y.</given-names></name><name><surname>Ma</surname><given-names>S. J.</given-names></name><name><surname>Li</surname><given-names>J. G.</given-names></name><name><surname>Shi</surname><given-names>M. F.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Study on miRNAs in pan-cancer of the digestive tract based on the illumina HiSeq system data sequencing.</article-title>
<source><italic>Biomed. Res. Int.</italic></source>
<volume>2019</volume>:<issue>8016120</issue>. <pub-id pub-id-type="doi">10.1155/2019/8016120</pub-id>
<?supplied-pmid 31737678?><pub-id pub-id-type="pmid">31737678</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>J.</given-names></name><name><surname>Crawford</surname><given-names>E. D.</given-names></name><name><surname>Peck</surname><given-names>D.</given-names></name><name><surname>Modell</surname><given-names>J. W.</given-names></name><name><surname>Blat</surname><given-names>I. C.</given-names></name><name><surname>Wrobel</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.</article-title>
<source><italic>Science</italic></source>
<volume>313</volume>
<fpage>1929</fpage>&#x02013;<lpage>1935</lpage>. <pub-id pub-id-type="doi">10.1126/science.1132939</pub-id>
<?supplied-pmid 17008526?><pub-id pub-id-type="pmid">17008526</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Xiang</surname><given-names>S.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets.</article-title>
<source><italic>Int. J. Biol. Sci.</italic></source>
<volume>16</volume>
<fpage>568</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.39769</pub-id>
<?supplied-pmid 32025206?><pub-id pub-id-type="pmid">32025206</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Miao</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>9</volume>:<issue>7827</issue>. <pub-id pub-id-type="doi">10.1038/s41598-019-43924-x</pub-id>
<?supplied-pmid 31127138?><pub-id pub-id-type="pmid">31127138</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Pang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>H.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Secreted phosphoprotein 1 (SPP1) and fibronectin 1 (FN1) are associated with progression and prognosis of esophageal cancer as identified by integrated expression profiles analysis.</article-title>
<source><italic>Med. Sci. Monit.</italic></source>
<volume>26</volume>:<issue>e920355</issue>. <pub-id pub-id-type="doi">10.12659/MSM.920355</pub-id>
<?supplied-pmid 32208405?><pub-id pub-id-type="pmid">32208405</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Dou</surname><given-names>Y.</given-names></name><name><surname>Gorospe</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>NSUN2-mediated m5C methylation and METTL3/METTL14-mediated m6A methylation cooperatively enhance p21 translation.</article-title>
<source><italic>J. Cell Biochem.</italic></source>
<volume>118</volume>
<fpage>2587</fpage>&#x02013;<lpage>2598</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.25957</pub-id>
<?supplied-pmid 28247949?><pub-id pub-id-type="pmid">28247949</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>You</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.</article-title>
<source><italic>Cell. Res.</italic></source>
<volume>27</volume>
<fpage>1243</fpage>&#x02013;<lpage>1257</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2017.121</pub-id>
<?supplied-pmid 28925386?><pub-id pub-id-type="pmid">28925386</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>A.</given-names></name><name><surname>Piao</surname><given-names>H. L.</given-names></name><name><surname>Zhuang</surname><given-names>L.</given-names></name><name><surname>Sarbassov dos</surname><given-names>D.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Gan</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.</article-title>
<source><italic>Cancer Res.</italic></source>
<volume>74</volume>
<fpage>1682</fpage>&#x02013;<lpage>1693</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1729</pub-id>
<?supplied-pmid 24448243?><pub-id pub-id-type="pmid">24448243</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Methylation modifications in eukaryotic messenger RNA.</article-title>
<source><italic>J. Genet. Genomics</italic></source>
<volume>41</volume>
<fpage>21</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgg.2013.10.002</pub-id>
<?supplied-pmid 24480744?><pub-id pub-id-type="pmid">24480744</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R. J.</given-names></name><name><surname>Long</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>E. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Structural basis for substrate binding and catalytic mechanism of a human RNA:m5C methyltransferase NSun6.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>45</volume>
<fpage>6684</fpage>&#x02013;<lpage>6697</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx473</pub-id>
<?supplied-pmid 28531330?><pub-id pub-id-type="pmid">28531330</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Ouyang</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>K.</given-names></name><name><surname>Gong</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>38</volume>
<fpage>W609</fpage>&#x02013;<lpage>W614</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq300</pub-id>
<?supplied-pmid 20430828?><pub-id pub-id-type="pmid">20430828</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Holzmann</surname><given-names>K.</given-names></name></person-group> (<year>2018</year>). <article-title>High tRNA transferase NSUN2 gene expression is associated with poor prognosis in head and neck squamous carcinoma.</article-title>
<source><italic>Cancer Invest.</italic></source>
<volume>36</volume>
<fpage>246</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1080/07357907.2018.1466896</pub-id>
<?supplied-pmid 29775108?><pub-id pub-id-type="pmid">29775108</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metodiev</surname><given-names>M. D.</given-names></name><name><surname>Spahr</surname><given-names>H.</given-names></name><name><surname>Loguercio Polosa</surname><given-names>P.</given-names></name><name><surname>Meharg</surname><given-names>C.</given-names></name><name><surname>Becker</surname><given-names>C.</given-names></name><name><surname>Altmueller</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly.</article-title>
<source><italic>PLoS Genet.</italic></source>
<volume>10</volume>:<issue>e1004110</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1004110</pub-id>
<?supplied-pmid 24516400?><pub-id pub-id-type="pmid">24516400</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motorin</surname><given-names>Y.</given-names></name><name><surname>Lyko</surname><given-names>F.</given-names></name><name><surname>Helm</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>5-methylcytosine in RNA: detection, enzymatic formation and biological functions.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>38</volume>
<fpage>1415</fpage>&#x02013;<lpage>1430</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp1117</pub-id>
<?supplied-pmid 20007150?><pub-id pub-id-type="pmid">20007150</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>S.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Kawarada</surname><given-names>L.</given-names></name><name><surname>Iwata</surname><given-names>H.</given-names></name><name><surname>Asano</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>NSUN3 methylase initiates 5-formylcytidine biogenesis in human mitochondrial tRNA(Met).</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>12</volume>
<fpage>546</fpage>&#x02013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2099</pub-id>
<?supplied-pmid 27214402?><pub-id pub-id-type="pmid">27214402</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oerum</surname><given-names>S.</given-names></name><name><surname>Degut</surname><given-names>C.</given-names></name><name><surname>Barraud</surname><given-names>P.</given-names></name><name><surname>Tisne</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>m1A post-transcriptional modification in tRNAs.</article-title>
<source><italic>Biomolecules</italic></source>
<volume>7</volume>:<issue>20</issue>. <pub-id pub-id-type="doi">10.3390/biom7010020</pub-id>
<?supplied-pmid 28230814?><pub-id pub-id-type="pmid">28230814</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogunleye</surname><given-names>A. J.</given-names></name><name><surname>Olanrewaju</surname><given-names>A. J.</given-names></name><name><surname>Arowosegbe</surname><given-names>M.</given-names></name><name><surname>Omotuyi</surname><given-names>O. I.</given-names></name></person-group> (<year>2019</year>). <article-title>Molecular docking based screening analysis of GSK3B.</article-title>
<source><italic>Bioinformation</italic></source>
<volume>15</volume>
<fpage>201</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.6026/97320630015201</pub-id>
<?supplied-pmid 31354196?><pub-id pub-id-type="pmid">31354196</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>M.</given-names></name><name><surname>Hirata</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Koga</surname><given-names>S.</given-names></name><name><surname>Fujii</surname><given-names>M.</given-names></name><name><surname>Qi</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Frequent increased gene copy number and high protein expression of tRNA (cytosine-5-)-methyltransferase (NSUN2) in human cancers.</article-title>
<source><italic>DNA Cell Biol.</italic></source>
<volume>31</volume>
<fpage>660</fpage>&#x02013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1089/dna.2011.1446</pub-id>
<?supplied-pmid 22136356?><pub-id pub-id-type="pmid">22136356</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Kanai</surname><given-names>Y.</given-names></name><name><surname>Sakamoto</surname><given-names>M.</given-names></name><name><surname>Saito</surname><given-names>H.</given-names></name><name><surname>Ishii</surname><given-names>H.</given-names></name><name><surname>Hirohashi</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.</article-title>
<source><italic>Hepatology</italic></source>
<volume>33</volume>
<fpage>561</fpage>&#x02013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1053/jhep.2001.22507</pub-id>
<?supplied-pmid 11230735?><pub-id pub-id-type="pmid">11230735</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>M.</given-names></name><name><surname>Lyko</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>Solving the Dnmt2 enigma.</article-title>
<source><italic>Chromosoma</italic></source>
<volume>119</volume>
<fpage>35</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1007/s00412-009-0240-6</pub-id>
<?supplied-pmid 19730874?><pub-id pub-id-type="pmid">19730874</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schosserer</surname><given-names>M.</given-names></name><name><surname>Minois</surname><given-names>N.</given-names></name><name><surname>Angerer</surname><given-names>T. B.</given-names></name><name><surname>Amring</surname><given-names>M.</given-names></name><name><surname>Dellago</surname><given-names>H.</given-names></name><name><surname>Harreither</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>6</volume>:<issue>6158</issue>. <pub-id pub-id-type="doi">10.1038/ncomms7158</pub-id>
<?supplied-pmid 25635753?><pub-id pub-id-type="pmid">25635753</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P.</given-names></name><name><surname>Markiel</surname><given-names>A.</given-names></name><name><surname>Ozier</surname><given-names>O.</given-names></name><name><surname>Baliga</surname><given-names>N. S.</given-names></name><name><surname>Wang</surname><given-names>J. T.</given-names></name><name><surname>Ramage</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks.</article-title>
<source><italic>Genome Res.</italic></source>
<volume>13</volume>
<fpage>2498</fpage>&#x02013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
<?supplied-pmid 14597658?><pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.</article-title>
<source><italic>Am. J. Cancer Res.</italic></source>
<volume>8</volume>
<fpage>435</fpage>&#x02013;<lpage>449</lpage>.<pub-id pub-id-type="pmid">29636999</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Squires</surname><given-names>J. E.</given-names></name><name><surname>Patel</surname><given-names>H. R.</given-names></name><name><surname>Nousch</surname><given-names>M.</given-names></name><name><surname>Sibbritt</surname><given-names>T.</given-names></name><name><surname>Humphreys</surname><given-names>D. T.</given-names></name><name><surname>Parker</surname><given-names>B. J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>40</volume>
<fpage>5023</fpage>&#x02013;<lpage>5033</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks144</pub-id>
<?supplied-pmid 22344696?><pub-id pub-id-type="pmid">22344696</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Narayan</surname><given-names>R.</given-names></name><name><surname>Corsello</surname><given-names>S. M.</given-names></name><name><surname>Peck</surname><given-names>D. D.</given-names></name><name><surname>Natoli</surname><given-names>T. E.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>A next generation connectivity map: L1000 platform and the first 1,000,000 profiles.</article-title>
<source><italic>Cell</italic></source>
<volume>171</volume>
<fpage>1437.e17</fpage>&#x02013;<lpage>1452.e17</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.10.049</pub-id>
<?supplied-pmid 29195078?><pub-id pub-id-type="pmid">29195078</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Xue</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells.</article-title>
<source><italic>Epigenomics</italic></source>
<volume>11</volume>
<fpage>439</fpage>&#x02013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.2217/epi-2018-0169</pub-id>
<?supplied-pmid 30526041?><pub-id pub-id-type="pmid">30526041</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szmida</surname><given-names>E.</given-names></name><name><surname>Karpinski</surname><given-names>P.</given-names></name><name><surname>Leszczynski</surname><given-names>P.</given-names></name><name><surname>Sedziak</surname><given-names>T.</given-names></name><name><surname>Kielan</surname><given-names>W.</given-names></name><name><surname>Ostasiewicz</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.</article-title>
<source><italic>J. Appl. Genet.</italic></source>
<volume>56</volume>
<fpage>185</fpage>&#x02013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1007/s13353-014-0253-6</pub-id>
<?supplied-pmid 25366420?><pub-id pub-id-type="pmid">25366420</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Dou</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation.</article-title>
<source><italic>Aging</italic></source>
<volume>7</volume>
<fpage>1143</fpage>&#x02013;<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100860</pub-id>
<?supplied-pmid 26687548?><pub-id pub-id-type="pmid">26687548</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>J. G.</given-names></name><name><surname>Bamford</surname><given-names>S.</given-names></name><name><surname>Jubb</surname><given-names>H. C.</given-names></name><name><surname>Sondka</surname><given-names>Z.</given-names></name><name><surname>Beare</surname><given-names>D. M.</given-names></name><name><surname>Bindal</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>COSMIC: the catalogue of somatic mutations in cancer.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>47</volume>
<fpage>D941</fpage>&#x02013;<lpage>D947</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1015</pub-id>
<?supplied-pmid 30371878?><pub-id pub-id-type="pmid">30371878</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomczak</surname><given-names>K.</given-names></name><name><surname>Czerwinska</surname><given-names>P.</given-names></name><name><surname>Wiznerowicz</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>The cancer genome atlas (TCGA): an immeasurable source of knowledge.</article-title>
<source><italic>Contemp. Oncol.</italic></source>
<volume>19</volume>
<fpage>A68</fpage>&#x02013;<lpage>A77</lpage>. <pub-id pub-id-type="doi">10.5114/wo.2014.47136</pub-id>
<?supplied-pmid 25691825?><pub-id pub-id-type="pmid">25691825</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toomey</surname><given-names>P. G.</given-names></name><name><surname>Vohra</surname><given-names>N. A.</given-names></name><name><surname>Ghansah</surname><given-names>T.</given-names></name><name><surname>Sarnaik</surname><given-names>A. A.</given-names></name><name><surname>Pilon-Thomas</surname><given-names>S. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Immunotherapy for gastrointestinal malignancies.</article-title>
<source><italic>Cancer Control</italic></source>
<volume>20</volume>
<fpage>32</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1177/107327481302000106</pub-id>
<?supplied-pmid 23302905?><pub-id pub-id-type="pmid">23302905</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traube</surname><given-names>F. R.</given-names></name><name><surname>Carell</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>The chemistries and consequences of DNA and RNA methylation and demethylation.</article-title>
<source><italic>RNA Biol.</italic></source>
<volume>14</volume>
<fpage>1099</fpage>&#x02013;<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2017.1318241</pub-id>
<?supplied-pmid 28440690?><pub-id pub-id-type="pmid">28440690</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trixl</surname><given-names>L.</given-names></name><name><surname>Lusser</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark.</article-title>
<source><italic>Wiley Interdiscip. Rev. RNA</italic></source>
<volume>10</volume>
<issue>e1510</issue>. <pub-id pub-id-type="doi">10.1002/wrna.1510</pub-id>
<?supplied-pmid 30311405?><pub-id pub-id-type="pmid">30311405</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuorto</surname><given-names>F.</given-names></name><name><surname>Liebers</surname><given-names>R.</given-names></name><name><surname>Musch</surname><given-names>T.</given-names></name><name><surname>Schaefer</surname><given-names>M.</given-names></name><name><surname>Hofmann</surname><given-names>S.</given-names></name><name><surname>Kellner</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis.</article-title>
<source><italic>Nat. Struct. Mol. Biol.</italic></source>
<volume>19</volume>
<fpage>900</fpage>&#x02013;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2357</pub-id>
<?supplied-pmid 22885326?><pub-id pub-id-type="pmid">22885326</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vedeld</surname><given-names>H. M.</given-names></name><name><surname>Goel</surname><given-names>A.</given-names></name><name><surname>Lind</surname><given-names>G. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Epigenetic biomarkers in gastrointestinal cancers: the current state and clinical perspectives.</article-title>
<source><italic>Semin. Cancer Biol.</italic></source>
<volume>51</volume>
<fpage>36</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2017.12.004</pub-id>
<?supplied-pmid 29253542?><pub-id pub-id-type="pmid">29253542</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijay</surname><given-names>G. V.</given-names></name><name><surname>Zhao</surname><given-names>N.</given-names></name><name><surname>Den Hollander</surname><given-names>P.</given-names></name><name><surname>Toneff</surname><given-names>M. J.</given-names></name><name><surname>Joseph</surname><given-names>R.</given-names></name><name><surname>Pietila</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>GSK3beta regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.</article-title>
<source><italic>Breast Cancer Res.</italic></source>
<volume>21</volume>:<issue>37</issue>. <pub-id pub-id-type="doi">10.1186/s13058-019-1125-0</pub-id>
<?supplied-pmid 30845991?><pub-id pub-id-type="pmid">30845991</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>M. L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>B.</given-names></name><name><surname>Zhu</surname><given-names>B. S.</given-names></name><name><surname>Cao</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways.</article-title>
<source><italic>Biosci. Rep.</italic></source>
<volume>40</volume>:<issue>BSR20200265</issue>
<pub-id pub-id-type="doi">10.1042/BSR20200265</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name></person-group> (<year>2016</year>). <article-title>mRNA methylation by NSUN2 in cell proliferation.</article-title>
<source><italic>Wiley Interdiscip. Rev. RNA</italic></source>
<volume>7</volume>
<fpage>838</fpage>&#x02013;<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1002/wrna.1380</pub-id>
<?supplied-pmid 27444144?><pub-id pub-id-type="pmid">27444144</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Pan</surname><given-names>C.</given-names></name><name><surname>Gong</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs.</article-title>
<source><italic>J. Chem. Inf. Model.</italic></source>
<volume>56</volume>
<fpage>1175</fpage>&#x02013;<lpage>1183</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00690</pub-id>
<?supplied-pmid 27187084?><pub-id pub-id-type="pmid">27187084</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>45</volume>
<fpage>W356</fpage>&#x02013;<lpage>W360</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx374</pub-id>
<?supplied-pmid 28472422?><pub-id pub-id-type="pmid">28472422</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z. X.</given-names></name><name><surname>Deng</surname><given-names>T. X.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name></person-group> (<year>2019</year>). <article-title>Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.</article-title>
<source><italic>J. Cell. Biochem.</italic></source>
<volume>120</volume>
<fpage>16416</fpage>&#x02013;<lpage>16426</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.28601</pub-id>
<?supplied-pmid 31297864?><pub-id pub-id-type="pmid">31297864</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>R.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name></person-group> (<year>2019</year>). <article-title>FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.</article-title>
<source><italic>J. Exp. Clin. Cancer Res.</italic></source>
<volume>38</volume>:<issue>112</issue>. <pub-id pub-id-type="doi">10.1186/s13046-019-1043-0</pub-id>
<?supplied-pmid 30832706?><pub-id pub-id-type="pmid">30832706</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>X. X.</given-names></name><name><surname>Wang</surname><given-names>J. R.</given-names></name><name><surname>Yang</surname><given-names>T. Y.</given-names></name><name><surname>Li</surname><given-names>X. M.</given-names></name><name><surname>He</surname><given-names>X. S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/beta-catenin degradation and is targeted for GSK3B/GSK3beta-mediated phosphorylation and degradation.</article-title>
<source><italic>Autophagy</italic></source>
<volume>15</volume>
<fpage>1506</fpage>&#x02013;<lpage>1522</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2019.1586250</pub-id>
<?supplied-pmid 30806153?><pub-id pub-id-type="pmid">30806153</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>NSun2 promotes cell growth via elevating cyclin-dependent kinase 1 translation.</article-title>
<source><italic>Mol. Cell. Biol.</italic></source>
<volume>35</volume>
<fpage>4043</fpage>&#x02013;<lpage>4052</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00742-15</pub-id>
<?supplied-pmid 26391950?><pub-id pub-id-type="pmid">26391950</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J. C.</given-names></name><name><surname>Risch</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival.</article-title>
<source><italic>Future Oncol.</italic></source>
<volume>13</volume>
<fpage>1981</fpage>&#x02013;<lpage>1990</lpage>. <pub-id pub-id-type="doi">10.2217/fon-2017-0084</pub-id>
<?supplied-pmid 28829218?><pub-id pub-id-type="pmid">28829218</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>B. F.</given-names></name><name><surname>Chen</surname><given-names>Y. S.</given-names></name><name><surname>Xu</surname><given-names>J. W.</given-names></name><name><surname>Lai</surname><given-names>W. Y.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader.</article-title>
<source><italic>Cell Res.</italic></source>
<volume>27</volume>
<fpage>606</fpage>&#x02013;<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2017.55</pub-id>
<?supplied-pmid 28418038?><pub-id pub-id-type="pmid">28418038</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer.</article-title>
<source><italic>Oncotarget</italic></source>
<volume>8</volume>
<fpage>20751</fpage>&#x02013;<lpage>20765</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.10612</pub-id>
<?supplied-pmid 27447970?><pub-id pub-id-type="pmid">27447970</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshino</surname><given-names>H.</given-names></name><name><surname>Enokida</surname><given-names>H.</given-names></name><name><surname>Itesako</surname><given-names>T.</given-names></name><name><surname>Tatarano</surname><given-names>S.</given-names></name><name><surname>Kinoshita</surname><given-names>T.</given-names></name><name><surname>Fuse</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.</article-title>
<source><italic>J. Hum. Genet.</italic></source>
<volume>58</volume>
<fpage>508</fpage>&#x02013;<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2013.31</pub-id>
<?supplied-pmid 23635949?><pub-id pub-id-type="pmid">23635949</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Jia</surname><given-names>W.</given-names></name><name><surname>An</surname><given-names>Q.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Bioinformatic analysis of GLI1 and related signaling pathways in chemosensitivity of gastric cancer.</article-title>
<source><italic>Med. Sci. Monit.</italic></source>
<volume>24</volume>
<fpage>1847</fpage>&#x02013;<lpage>1855</lpage>. <pub-id pub-id-type="doi">10.12659/msm.906176</pub-id>
<?supplied-pmid 29596399?><pub-id pub-id-type="pmid">29596399</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Methylation by NSun2 represses the levels and function of microRNA 125b.</article-title>
<source><italic>Mol. Cell. Biol.</italic></source>
<volume>34</volume>
<fpage>3630</fpage>&#x02013;<lpage>3641</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00243-14</pub-id>
<?supplied-pmid 25047833?><pub-id pub-id-type="pmid">25047833</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu-Jing</surname><given-names>T.</given-names></name><name><surname>Wen-Jing</surname><given-names>T.</given-names></name><name><surname>Biao</surname><given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Integrated analysis of hub genes and pathways in esophageal carcinoma based on NCBI&#x02019;s gene expression omnibus (GEO) database: a bioinformatics analysis.</article-title>
<source><italic>Med. Sci. Monit.</italic></source>
<volume>26</volume>:<issue>e923934</issue>. <pub-id pub-id-type="doi">10.12659/MSM.923934</pub-id>
<?supplied-pmid 32756534?><pub-id pub-id-type="pmid">32756534</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>A deregulated PI3K-AKT signaling pathway in patients with colorectal cancer.</article-title>
<source><italic>J. Gastrointest. Cancer</italic></source>
<volume>50</volume>
<fpage>35</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s12029-017-0024-9</pub-id>
<?supplied-pmid 29110225?><pub-id pub-id-type="pmid">29110225</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The tRNA methyltransferase NSun2 stabilizes p16INK(4) mRNA by methylating the 3&#x02019;-untranslated region of p16.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>3</volume>:<issue>712</issue>. <pub-id pub-id-type="doi">10.1038/ncomms1692</pub-id>
<?supplied-pmid 22395603?><pub-id pub-id-type="pmid">22395603</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>M. E.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Ge</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network.</article-title>
<source><italic>Cancer Cell. Int.</italic></source>
<volume>19</volume>:<issue>148</issue>. <pub-id pub-id-type="doi">10.1186/s12935-019-0866-2</pub-id>
<?supplied-pmid 31164794?><pub-id pub-id-type="pmid">31164794</pub-id></mixed-citation></ref></ref-list></back></article>